Skip to content
Precision for Medicine
Press Release

Precision Medicine Group joins McKesson's Oncology & Multispecialty segment. Read more in McKesson Business Highlights.

fig_image_2_55

eBook

Epiontis ID® for DNA-Based Immune Monitoring​

Quantify Immune Cell Populations without Flow Cytometry​

eBook

Read immune identity written in DNA. Expand sample options and scale beyond viable cell workflows.​

Many immune monitoring approaches depend on living cells, which have tight processing windows and site-level lab requirements that drive up cost, logistical complexity, and sample viability risk as studies grow.​

Epiontis ID takes a different approach. By reading DNA methylation markers that remain stable in dried, frozen, and fixed samples, it delivers immune cell counts without relying on intact cells – offering a flexible, scalable, and cost-effective platform that Precision for Medicine uniquely provides.​

When and why are sponsors choosing Epiontis ID?​

This eBook guide provides an in-depth look at the science behind DNA-based immune monitoring and the optimal applications for Epiontis ID as an orthogonal or alternative approach to flow cytometry. You’ll discover:​

  • Why virtually any sample containing human DNA can be analyzed, whether whole blood, dried blood spots, tissue, or biofluids.​

  • The menu of fully validated Epiontis ID assays available, spanning diverse immune cell populations.​
  • Guidance on when to choose Epiontis ID, flow cytometry, or a complementary approach.​

  • Real-world case studies in which Epiontis ID has been used to advance clinical studies.​

 
Download the full eBook to see how Epiontis ID can expand what’s possible for immune monitoring in your studies.​
 
epiontis-id-ebook-dna-based-immune-monitoring

Get the Full eBook Instantly